The role of hypoxia inducible factor-1 in hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

The role of hypoxia inducible factor-1 in hepatocellular carcinoma.

The role of hypoxia inducible factor-1 in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q33914603

about

Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances Hepatocellular carcinoma: Review of disease and tumor biomarkers Hypoxia-inducible factors as molecular targets for liver diseases Low temperature plasmas as emerging cancer therapeutics: the state of play and thoughts for the future The Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver Disease Epigenetic Therapy for Solid Tumors: Highlighting the Impact of Tumor Hypoxia Targeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer Cells Regulation of Multi-drug Resistance in hepatocellular carcinoma cells is TRPC6/Calcium Dependent.Designing a broad-spectrum integrative approach for cancer prevention and treatment.Hypoxia and P. gingivalis synergistically induce HIF-1 and NF-κB activation in PDL cells and periodontal diseases.Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target Targeting hypoxia-inducible factor-2α enhances sorafenib antitumor activity via β-catenin/C-Myc-dependent pathways in hepatocellular carcinoma.Bortezomib enhances the radiosensitivity of hypoxic cervical cancer cells by inhibiting HIF-1α expression.A sucrose-binding site provides a lead towards an isoform-specific inhibitor of the cancer-associated enzyme carbonic anhydrase IX.Clinicopathological Significance of MicroRNA-20b Expression in Hepatocellular Carcinoma and Regulation of HIF-1α and VEGF Effect on Cell Biological Behaviour.Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.Small ubiquitin-related modifier 1 is involved in hepatocellular carcinoma progression via mediating p65 nuclear translocation.Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells.Twist1 Enhances Hypoxia Induced Radioresistance in Cervical Cancer Cells by Promoting Nuclear EGFR Localization.Targeting carbonic anhydrase IX activity and expression.Fucoidan Suppresses Hypoxia-Induced Lymphangiogenesis and Lymphatic Metastasis in Mouse Hepatocarcinoma.Hepatocellular carcinoma is accelerated by NASH involving M2 macrophage polarization mediated by hif-1αinduced IL-10 Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies.Oroxylin A regulates glucose metabolism in response to hypoxic stress with the involvement of Hypoxia-inducible factor-1 in human hepatoma HepG2 cells.Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling.Effect of prolyl hydroxylase domain 2 haplodeficiency on liver progenitor cell characteristics in early mouse hepatocarcinogenesis Tetrahydrocurcumin induces mesenchymal-epithelial transition and suppresses angiogenesis by targeting HIF-1α and autophagy in human osteosarcoma.Increased expression of stemness markers and altered tumor stroma in hepatocellular carcinoma under TACE-induced hypoxia: A biopsy and resection matched study.Hypoxia-Inducible Factors and Cancer.Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma.Increased mediator complex subunit 15 expression is associated with poor prognosis in hepatocellular carcinoma.Hepatocellular carcinoma cells surviving doxorubicin treatment exhibit increased migratory potential and resistance to doxorubicin re-treatment in vitro.The association of HIF-1α expression with clinicopathological significance in prostate cancer: a meta-analysis

P2860

Q26745338-30556A1A-3B4C-4EDD-8577-5DA90E25E6EC Q26750796-F37A5087-268B-4493-A863-F8E42EEB4459 Q26752304-3D9642C1-EA88-40BD-9040-08415BA8E81A Q26765057-631AFCE2-6CD7-4611-879D-732BF01688A9 Q26780509-8A42BF6C-B76D-409A-9535-49EDB3955901 Q26783014-80DB7074-00AB-4A5F-905C-6D3B4861CD80 Q26798203-C72A6E1F-6556-47F5-8C95-CBF4F22DFA38 Q27330365-7BF18A5F-550C-4C4E-8645-3208432B6ED0 Q30736359-F3AD5BA6-F671-4471-AD75-D16C235E5C64 Q35227164-A1D0A5C6-BF99-4FB7-9AE7-FA439547835E Q35825993-D4A30AAB-A74F-4245-B00C-587A7C0388E1 Q35843846-23AF6BD5-DD01-429A-B9A9-A0EE041BE60D Q35870450-C00156E3-4720-4F41-B3E6-6FC13032CFAE Q36095138-A1DF51FC-CEC1-4B83-8488-6586779CFDD5 Q36148199-B09F6A3A-0A84-470B-9506-E065C20DAF7A Q36285231-A9D76BE9-4ECD-4A90-ADED-045727259F79 Q37190269-15B6B52E-E4C1-46B0-AFC5-903DC385CA09 Q37225511-2B731F97-DD03-4853-934F-948E7DA76552 Q37362644-F32BFB6E-6387-4264-ABB0-0583D89DD8B1 Q37675930-EE9C4B17-802D-4DCA-BDC8-47219A8107D9 Q38342634-2194104B-CE58-4116-B485-A50A04D62861 Q38867010-0C700BB4-E98F-4E47-A8CB-A045956B7A56 Q39181831-6882B20B-8954-4583-A540-754E95CA271C Q39458547-6BCDBDDA-5F3F-403A-AB2D-3D55E987B799 Q40641042-61C8B4E1-98E1-4DC4-A3A6-DE465A13439A Q42281562-8540725C-8130-4C7A-A76C-BBEE0D375D9F Q42320592-9D72D30C-7FE6-4CF5-9536-DA8546C52D29 Q47107018-380FE572-1987-46EA-8659-959E5DBA73BE Q47136607-B0483BC2-B2B8-404A-8835-3D37F66D88C9 Q47681462-A6ACA0F2-3578-47FE-B173-885AF989F599 Q49796251-AAAD47E8-23EE-4DBA-BBDD-05D7136A4B39 Q52349563-4D6EFB4E-7706-4FE6-8AB0-DB3D07091855 Q52655130-33FCF697-2B47-4CA2-B16C-F40655C67D49 Q57107650-C1141518-574A-4998-808D-BDE9C42689E3

P2860

The role of hypoxia inducible factor-1 in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q33914603

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

The role of hypoxia inducible factor-1 in hepatocellular carcinoma.

@ast

The role of hypoxia inducible factor-1 in hepatocellular carcinoma.

@en

type

label

The role of hypoxia inducible factor-1 in hepatocellular carcinoma.

@ast

The role of hypoxia inducible factor-1 in hepatocellular carcinoma.

@en

prefLabel

The role of hypoxia inducible factor-1 in hepatocellular carcinoma.

@ast

The role of hypoxia inducible factor-1 in hepatocellular carcinoma.

@en

P1433

Q33914603-57F4C8B5-1BE2-4610-9021-B3ED9051467A

P1476

Q33914603-4314DABC-46E4-4EC6-A789-F77C7EDD241A

P2093

Q33914603-0EBBA795-E043-4806-8BFD-788F32C54949

Q33914603-257E3950-8E20-4E5C-9C87-45B7D65A96B5

Q33914603-6C45B80D-A308-4144-BAA3-8FDB853083A9

Q33914603-F813A16C-93F8-46A2-8065-7D6270374E54

P275

Q33914603-A48A06D0-3EBF-4F65-A433-2CEC7B612849

P2860

Q33914603-017AE71C-9E9D-4CAC-8154-29A58F2089EE

Q33914603-01C51E5F-440A-44DE-8780-97A608557EFB

Q33914603-02F1F241-F9D5-46D7-B982-358184A39022

Q33914603-03F61C7D-6DB7-44EC-B295-6FAA35D569C3

Q33914603-04CD31FC-3B9E-4E6E-BDBF-65CC08DCEE2E

Q33914603-0681E9DB-65CD-4A1F-A0E4-60E6D94879CF

Q33914603-0A72B855-7105-43A3-A5FB-BAB1CBDB582E

Q33914603-15FE5B3D-AE9B-46D2-931B-7B2D5C6445F0

Q33914603-2286CBCB-58DD-419B-89A1-81604AAC7533

Q33914603-22DC1F02-F967-4A4E-B2EC-D77577E99C9C

P304

Q33914603-BB1DE08E-C5A6-4148-85F5-72B97B1EF780

P31

Q33914603-59F31AAF-5D0E-4129-9B84-36816A9F8C2D

Q33914603-5F27833C-7E49-476D-AD86-8B907C4E16F8

P356

Q33914603-401C4473-025C-41DF-AA7E-D65F027F356F

P407

Q33914603-24B32576-0FD0-4EE7-8C1B-1733F6D706E5

P478

Q33914603-098CBA45-E755-453D-A4D3-D3533FD52220

P50

Q33914603-2EC7B875-6AA3-4F18-AEB6-757096E44875

P5008

Q33914603-9AF9C2E0-CFFD-4897-A6BB-A42915DA8CEE

P577

Q33914603-C32756E9-A33F-4A26-BE85-7C90A59085D3

P5875

Q33914603-7C1EECD9-6D5A-415C-91E0-7708C4F53D8D

P698

Q33914603-33DFAE04-C19F-4284-9A14-DAE9EAAE65E6

P921

Q33914603-01E0F680-0E55-4752-AEC8-66394A4D8BB3

Q33914603-0F8F6CE7-1286-467E-B887-19D94D953BDE

Q33914603-24030794-6D64-4250-A3EA-DE9EC041484C

Q33914603-4163C283-00AB-4E59-9C9F-0CEE162F543F

Q33914603-5C54A100-26A0-4670-B2E4-FDB028D4187C

Q33914603-D0F35F8E-7409-478E-904F-690DD2EC4F5B

P932

Q33914603-6646FF3F-E0ED-469B-A40C-73C288A2E55C

P356

P1433

BioMed Research International

P1476

The role of hypoxia inducible factor-1 in hepatocellular carcinoma.

@en

P2093

Chunping Jiang

http://www.w3.org/2001/XMLSchema#string

Dongjun Luo

http://www.w3.org/2001/XMLSchema#string

Junyi Wu

http://www.w3.org/2001/XMLSchema#string

Zhongxia Wang

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation

RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia

SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia

Direct regulation of TWIST by HIF-1alpha promotes metastasis

HIF-1: upstream and downstream of cancer metabolism

HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia

Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells

RNAi and miRNA in viral infections and cancers

Role of microRNAs in hepatocellular carcinoma: a clinical perspective

Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases

P304

409272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/409272

http://www.w3.org/2001/XMLSchema#string

P407

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2014-07-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264641714

http://www.w3.org/2001/XMLSchema#string

P698

25101278

http://www.w3.org/2001/XMLSchema#string

P921

hepatocellular carcinoma

DNA-binding protein

transcription factor

P932

4101982

http://www.w3.org/2001/XMLSchema#string